Objective. At present, the potential benefits of psychologically oriented approaches to pain management for patients waiting to undergo medical interventions, such as neuromodulation, remain unclear. Therefore, this study aimed to examine the results of an interdisciplinary treatment based on principles of Acceptance and Commitment Therapy (ACT) delivered to a group of patients being considered for a neuromodulation procedure.
Introduction
Chronic pain treatment can be approached in different ways, such as with medications, interventional procedures, or with psychological methods. In turn, each of these approaches targets different mechanisms of action and potentially different primary outcomes. Generally, medical and interventional treatments aim to reduce pain. In contrast, psychological treatments, such as cognitive behavioral therapy (CBT), tend not to focus directly on pain reduction but on cognitive and behavior change. Typically, providers of each of these types of treatment hope to achieve improvements in overall health and functioning. In most of these treatments, this is expected to result from pain reduction, requiring a small to moderate degree of active patient engagement. In CBT, it is expected to result from a substantial degree of active patient participation, learning, and integration of new patterns of behavior. There are often calls to integrate pain reducing treatments with CBT as a way to enhance overall benefits [1, 2] . It is not clear how to best combine these approaches or whether their contrasting therapeutic processes might create confusion or undermine impact in some cases.
Since the earliest developments of CBT-based approaches to chronic pain, eligibility for these treatments has required that patients should "have no additional medical or surgical procedures being planned" (p. 358, [3] ). A usual focus for the assessment process prior to cognitive behavioral treatments is to determine that "all reasonable diagnostic and treatment procedures have been tried in the past" (p. 49, [4] ). In part, these requirements are expected to facilitate a process of reconceptualization for the person with chronic pain, including a switch from viewing pain as a medical problem that requires a doctor toward viewing it as a self-management problem that can be treated predominantly through active collaboration. Logically, a person's level of motivation for making the types of behavior changes required in cognitive behavioral treatments ought to hinge on whether they view themselves as responsible for producing the changes needed [5] .
There is keen interest in identifying predictors of outcome from invasive medical procedures, such as lumbar surgery and spinal cord stimulators (SCS) for chronic pain, including potential psychological predictors [6, 7] . Even though a clear consensus has not emerged on precisely who will succeed or fail with these treatments, it is clear that psychological factors may be associated with outcomes [8] . It is recommended that persons seeking SCS or similar procedures should undergo a comprehensive psychological assessment and then receive treatments to address psychological risk factors identified during this process [9, 10] . Of course, providing psychologically based treatments to address risks for poor surgical outcome depends in part on our understanding of how best to combine these treatments to optimize outcome.
There is evidence that psychological and surgical treatments can be combined to good effect [11] and that multidisciplinary treatments that include psychological methods can improve patient quality of life when used in conjunction with medication prescribed for chronic pain [12] . One study showed that the combined use of CBT and "spinal implantable devices" (SIDs) is associated with significant additional benefits, in the form of reduced emotional distress and disability, for people with chronic pain who achieve a suboptimal response to an initial treatment [13] . In this study, only a small number of subjects (n = 10) first underwent the CBT and then the SID, compared with a larger group who first underwent the SID (n = 31). In contrast to the results from this study, there has been a failure to achieve expected additive benefits from combining lumbar surgery with a subsequent behavioral psychological treatment [14] . Thus, we know relatively little about whether the order of these treatments matters. We also know little about whether the effectiveness of CBT-based approaches is in any way undermined by the availability of access to a pending medical procedure.
The purpose of this study was to examine the results from a brief interdisciplinary treatment based on principles of CBT delivered to adults with chronic pain seeking neuromodulation-based treatment, primarily SCS. The specific forms of CBT principles examined here are those underlying Acceptance and Commitment Therapy (ACT) [15, 16] . Consecutive patients referred to a 2-week, interdisciplinary, "preneuromodulation" treatment were studied in terms of standard treatment outcome variables and psychotherapeutic process variables [17, 18] . We predicted that participants would achieve significant improvements in outcome and that these improvements would correlate with changes in the proposed process variables. Secondarily, we planned to explore whether outcomes from the "preneuromodulation" treatment appear to have any bearing on patients' subsequent progression along the neuromodulation pathway: whether patients were promoted to the SCS trial and then moved on to the full implantation of the device. In particular, we were interested to find whether people successful from the initial 2-week treatment might opt not to proceed with the trial and implantation.
Methods

Participants
Participants were consecutive referrals to a 2-week, interdisciplinary, residential, pain management course at a comprehensive pain treatment center in central London (UK). They entered treatment between January 2012 and January 2013. They were enrolled in this program as part of a process of being considered for neuromodulation treatment. Prior to referral to the preneuromodulation program, all patients were evaluated by a consultant pain physician to determine their medical suitability for neuromodulation. Once referred to the program, all patients were further assessed by a specialist physiotherapist and psychologist to further consider their suitability for the SCS implantation and the preneuromodulation program. Potential participants were considered appropriate for inclusion in this program if they suffered persistent pain of greater than 3 months duration, demonstrated significant levels of pain-related distress and disability, were considered medically appropriate for neuromodulation, and were deemed likely to benefit from the 2-week treatment.
One hundred and four patients with chronic pain began the 2-week program. Six patients did not complete it and were therefore excluded from data analyses. An additional 12 were excluded due to substantially incomplete data. Thus, the total sample analyzed included 86 patients (48 women, 38 men). Patients in this sample had a mean age of 49.2 years (standard deviation [SD] = 12.8 years) and a mean pain duration of 123.6 months (SD = 111.4 months). The most common pain sites reported were pain in the lower back (54.7% of patients) and lower limbs (27.9%). Based on a review of medical records, most of the participants-53 of 86 patients (61.6%)-had back surgery prior to being referred for SCS, 24 of these (27.9% of total) were formally diagnosed with "failed back surgery syndrome," nine of the 86 patients (10.5%) had a formal diagnosis of complex regional pain syndrome, and the remainder had a mix of other diagnoses. The majority of patients (91.9%) were white. The majority of patients (51.2%) were unemployed. Further background details are included in Table 1 . All patients provided consent for their data to be used for research and the project received ethical approval.
Measures
Patients underwent a baseline evaluation on their first day of the 2-week program during which they provided background information, including their gender, age, ethnicity, pain history, pain sites, living situation, work status, and medications. They also rated their average pain in the past week on a standard scale from 0 (no pain) to 10 (worst pain possible) and completed a standard measures of treatment outcome and processes (described next). Patients completed the same measures at the completion of the 2-week program. All data were entered and analyzed using SPSS version 21 (IBM SPSS Statistics, www-01.ibm.com/software/analytics/spss/). Additional patient details and follow-up status with respect to the neuromodulation trial and permanent implantation were collected from a subsequent review of medical charts.
Patient Health Questionnaire
The Patient Health Questionnaire (PHQ)-9 [19] was used to measure symptoms of depression, based on the standard diagnostic criteria. On this measure, patients report on the frequency with which they experience nine symptoms of depression from 0 (not at all) to 3 (nearly every day). One additional item assesses the impact of these symptoms on work, home, and social activities. The total score of the first nine items reflects the severity of symptoms, with higher scores indicating more severe depression. The PHQ-9 has been well validated among patients with chronic health conditions [19] .
Short-Form Health Survey
The Short-Form Health Survey (SF-36) [20] is a standardized measure of health status consisting of 36 items. The SF-36 yields eight subscale scores assessing various domains of life functioning. The physical and social function and mental health subscales were used for the purpose of the present study. Higher scores indicate better functioning in these domains. The SF-36 has been validated and widely used as a measure of health status and function among patients with chronic pain [21] .
Chronic Pain Acceptance Questionnaire
The Chronic Pain Acceptance Questionnaire (CPAQ) [22] is a 20-item measure of acceptance of chronic pain. The CPAQ consists of two subscales: "Activity Engagement," which reflects performing desired activities in the presence of pain, and "Pain Willingness," which reflects the absence of attempts to control or reduce pain. Patients are asked to rate each item on a numerical scale from 0 (never true) to 6 (always true), with higher total scores reflecting greater acceptance of pain. There is extensive evidence for the reliability, factor structure, and validity of the CPAQ [23, 24] .
Committed Action Questionnaire
The Committed Action Questionnaire (CAQ) [25] was used to assess committed action, which can be defined briefly as flexible persistence of goal-directed behavior. On this measure, individuals indicate the degree to which each of 18 items applies to them on a 7-point scale ranging from 0 (never true) to 6 (always true). Higher scores reflect greater levels of committed action. The CAQ was recently shown to be reliable and valid for use among patients with chronic pain [25] .
Follow-Up Implantation Outcomes
Medical records were reviewed to ascertain patient outcomes related to SCS implantation following completion of the 2-week program. The following outcomes were assessed for the present analyses: whether patients went for trial implantation (yes/no) and, if not, whether this was principally the patient's or physician's decision; whether the trial implantation was successful (yes/no); and whether patients received the full implantation (yes/no). Trials were deemed successful if patients received at least a 50% reduction in their pain, the stimulator provided sufficient coverage of the pain area, and the stimulator leads remained in place during the trial period, indicating less likelihood of lead migration during full implantation. On the basis of this information, the clinical team decided whether full implantation was appropriate.
Treatment Program
The 2-week treatment applied principles and methods of ACT within an interdisciplinary rehabilitation context. The aim of the treatment is to improve overall patient functioning and decrease disability, and to leave patients in a better position to benefit from a subsequent neuromodulation procedure. Treatment was provided in a group format and consisted of 5 days of treatment per week for 2 weeks. The treatment is delivered by a team of psychologists, occupational and physical therapists, nurses, and physicians. Although different disciplines are represented in the treatment program, the implementation of interventions across these disciplines is based on the principles and methods of ACT. The methods are designed to explicitly target the key processes of psychological inflexibility. Thus, treatment aimed to facilitate openness toward pain and other distressing experiences, present-focused awareness, and value-based and committed action. To this end, experiential exercises, metaphor, mindfulness practice, cognitive defusion techniques, value-and goals-focused methods, as well as physical exercise and standard rehabilitation approaches to disability, are used (e.g., Hayes et al. and McCracken [26, 27] ). Some of the sessions also focus on education about the neuromodulation treatment.
Data Analysis
Means and SDs were computed for outcome and process measures at pre-and post-treatment. Independent samples t-tests were computed to examine differences on study variables for treatment completers and noncompleters. Repeated measures analyses of variance (ANOVAs)
were computed to determine the statistical significance of changes in outcome and process variables from pre-to post-treatment. Within-subjects effect sizes (Cohen's d) were computed as the difference between pre-and posttreatment means divided by the pretreatment SD. To evaluate the clinical significance of treatment-related changes, we identified the proportion of patients whose raw change scores were greater than one-half of a SD from their baseline score for each respective outcome and process variable [28] . This approach to determining clinically meaningful change has the advantage of being uniformly applicable to any continuous measure.
To assess the associations among changes in treatment outcome and process variables, we first computed residualized change scores for each of these variables. Pearson correlations were then calculated to examine the associations among each treatment process and outcome variable. On the basis of zero-order correlations, hierarchical multiple regression analyses were performed to determine the unique contribution of change in process variables to change in each outcome variable when controlling for relevant background variables and treatment changes in pain. Frequencies were computed for follow-up implantation outcome data, including advancement to the trial and to the permanent implant. One-way ANOVAs and independent samples t-tests were computed to examine differences on post-treatment and raw change scores on study variables according to these follow-up implantation outcomes.
Results
Independent samples t-tests indicated that participants who did not complete treatment (n = 6) scored significantly lower on pretreatment pain acceptance (M = 34.67, SD = 16.65) than those who completed treatment (M = 49.87, SD = 18.59), t (90) = 1.95, P = 0.05. Treatment completers and noncompleters did not differ significantly in terms of their scores on pretreatment pain intensity, depression, physical functioning, social functioning, mental health, or committed action.
Statistical Significance of Pre-to PostTreatment Changes
Mean scores on pre-and post-treatment outcome and process variables appear in Table 2 . Mean pretreatment scores on these variables are similar (i.e., within one SD of the mean) to those reported in previous studies of patients with chronic pain [29] [30] [31] . Repeated measures ANOVAs indicated statistically significant improvements from pre-to post-treatment for all outcome and process variables. Effect size magnitudes for each outcome and process variable are presented in Table 2 . Following standard guidelines, changes on all outcome measures showed a medium effect. Changes on pain acceptance approached a medium effect (d = 0.48), while changes on committed action (d = 0.28) showed a small effect.
Clinical Significance of Pre-to PostTreatment Changes
Individual pre-to post-treatment change on an outcome or process variable greater than one-half of the SD of the baseline value on that variable (in the therapeutic direction) was used as an indicator of clinically significant improvement. Patients meeting this criterion were coded as "significantly improved." Those whose treatment scores worsened by more than one one-half of the SD were coded as "significantly worsened." Lastly, those who neither improved nor worsened by one-half of the SD of the pretreatment mean were coded as "not significantly improved." The frequencies of patients falling into these categories for each study variable are reported in Table 3 .
As can be seen in Table 3 , the majority of patients showed a clinically significant improvement on all outcome variables, with the exception of mental health, where the majority showed no change (53.49%). In terms of process measures, a majority showed significant improvement on acceptance but not on committed action, where the majority showed no significant change (51.16%). Taking four of the outcome variables as a set in combination, including depression, physical functioning, mental health, and social functioning, we find that 89.5% of participants showed clinically significant improvements on at least one of these variables, 72.1% on at least two, 40.7% on at least three, and 18.6% on all four. There were participants whose data showed clinical significant worsening of their outcome, ranging from 2.3% for mental health to 17.4% for social functioning. Around 11% and 12% showed significant reductions in acceptance and committed action.
Relationships among Change in Treatment Process and Outcome Variables
Correlations among residualized change scores for pain acceptance and committed action with changes in outcome variables are shown in Table 4 . Change in pain acceptance was significantly correlated with change in each of the outcome variables, with the exception of pain intensity. Change in committed action was significantly correlated with change in depression, mental health, and physical function. Changes in acceptance and committed action were significantly correlated with each other. Table 4 Correlations among pre-to post-treatment residualized change scores for outcome and process variables controlling for demographic factors and change in pain. Pain intensity was not examined as an outcome variable in these regression analyses as changes in acceptance and committed action were not significantly correlated with change in pain in zero-order analyses.
In the first regression analysis, pain acceptance and committed action contributed significant unique variance to the prediction of improvement in depression, above and beyond that accounted for by demographic factors and treatment changes in pain intensity, ΔR 2 = 0.35, F (2, 80) = 22.71, P ≤ 0.001. Examination of the beta weights from the final regression equation indicated that only change in pain acceptance contributed significant unique variance to change in depression β = −0.49, t (85) = −4.46, P < 0.001. In the second regression analysis, pain acceptance and committed action contributed significant unique variance to the prediction of improvement in mental health, above and beyond that accounted for by demographic factors and treatment change in pain intensity, ΔR 2 = 0.28, F (2, 80) = 15.95, P ≤ 0.001. Examination of the beta weights from the final regression equation indicated that only change in pain acceptance contributed significant unique variance to change in mental health β = 0.49, t (85) = 4.21, P < 0.001. In the third regression analysis, changes in pain acceptance and committed action contributed significant unique variance to the prediction of improvement in physical functioning, above and beyond that accounted for by demographic factors and treatment change in pain intensity, ΔR 2 = 0.15, F (2, 80) = 7.46, P ≤ 0.05. Examination of the beta weights from the final regression equation indicated that only change in pain acceptance contributed significant unique variance to change in physical functioning β = 0.40, t (85) = 3.21, P < 0.05.
In zero-order correlations, only change in pain acceptance was significantly correlated with change in social functioning; therefore, only this process variable was entered in the final regression for this variable. In this analysis, pain acceptance contributed significant unique variance to the prediction of social functioning, above and beyond that accounted for by treatment changes in pain intensity, ΔR 2 = 0.13, F (2, 83) = 13.35, P < 0.001. Examination of the beta weights from the final regression equation indicated that both gender and change in pain acceptance contributed significant unique variance to changes in social functioning β = 0.23, t (85) = 2.15, P < 0.05, β = 0.37, and t (85) = 3.65, P < 0.001, respectively.
Examination of Implantation Outcomes
Complete data on progression on the implantation pathway were available for 85 of the 86 patients. Of these, 66 patients (77.7%) received the implantation trial, 13 (15.3%) did not receive the trial at their physicians' request, and six (7.1%) did not receive the trial due to their own choice. Of those who went for a trial, 46 (69.7%) patients were deemed successful, 17 (25.8%) were deemed unsuccessful, and three (4.6%) were still awaiting review. Of those deemed successful, 44 (95.7%) patients received the full implantation and two (4.4%) did not due to medical contraindications.
One-way ANOVAs were computed to examine differences between patients who received a trial of the implantation and those who did not in terms of their scores on pain, functioning, depression, pain acceptance, and committed action following the 2-week program. Significant differences were observed between the groups in terms of post-treatment pain intensity, depression, mental health, and pain acceptance. Following significant one-way ANOVAs, post hoc pairwise comparisons were computed using the Student-Newman-Keuls procedure. Table 6 displays the results of these analyses. Similar ANOVAs were computed for raw pre-to post-treatment change scores as a function of whether patients proceeded to the implantation trial. The magnitude of changes in pain intensity differed significantly between the groups of those who did and did not proceed to the trial (Table 6) . No other differences were observed between the groups in terms of the magnitude of changes during the preneuromodulation treatment.
Independent samples t-test were computed to compare post-treatment and treatment change scores on study variables for patients according to the success of their trial implantation. No significant differences were observed on any post-treatment scores or treatment-related changes in study variables for patients whose trial was successful and those whose trial was deemed unsuccessful.
Discussion
The purpose of the present study was to examine the utility of a brief interdisciplinary treatment program based on principles of CBT for adults with chronic pain seeking neuromodulation-based treatment. The main finding in the current study is that people seeking neuromodulation treatment for chronic pain appear able to demonstrate improvements in pain and in emotional, physical, and social functioning during this brief treatment provided before they progress for the neuromodulation procedure. Further, the specific form of CBT upon which the interdisciplinary program was based, ACT, was associated with changes in two key therapeutic processes variables: pain acceptance and committed action. Change in these processes was associated with improvements in the outcomes observed; however, in multivariate analyses, only change in acceptance made a significant contribution to outcome. While the effects of specific components of the treatment program cannot be determined from this study, these results provide preliminary support for the utility of increasing ACT-related processes in this context.
All of the measured treatment outcome and process variables showed statistically significant improvements. Between 44% and 70% of patients showed clinically significant change following the 2-week program across the set of outcomes, including depression, physical functioning, mental health, or social functioning. Thus, on average across these outcomes, 55% of patients experienced meaningful change. Taking this same set of outcomes, about nine out of 10 participants showed clinically significant improvement on at least one of these four, about seven out of 10 on at least two, four out of 10 on at least three, and two out of 10 on all four. At the same time, there were significant rates of people whose results reflected significant worsening of pain (15%) and an unexpected 17% whose data reflected a reduction in social functioning. These results deserve further investigation. If these results reflect a significant worsening of outcome, if they come with no collateral or compensating improvement in other domains, and if these results persist, some ways to mitigate them may be needed. Given the observational design of this study, it is not possible to determine with certainty whether these observed benefits or detriments can be attributed to the treatment examined here.
The small effect size for change on committed action and the lack of a unique contribution to outcome changes from this variable are inconsistent with the intended focus of the treatment. This may mean that methods within the treatment designed to increase committed action need to be more focused or delivered with higher intensity. It is possible that the brief 2-week interval of the treatment, or the residential treatment context, does not support greater development and integration of patterns of committed action. Perhaps committed action emerges later, during follow-up. Alternately, it may be that creating committed action is an aspect of behavior change that is relatively harder to shift in people expecting a neuromodulation procedure. The present study may have also lacked power to detect the unique predictive utility of committed action. These speculations will require further study.
Examination of patient follow-up status indicated that the large majority of patients in the premodulation program subsequently proceeded to receive a trial of the SCS (n = 66; 77.7%), and nearly all of those who had a successful trial (n = 46; 69.7%) also underwent the full implantation of the device (n = 44; 95.7%). Interestingly, significant differences were observed between patients who received and did not receive the initial trial on several study variables at post-treatment. The post-treatment pain scores of patients who themselves decided not to proceed to trial implant were significantly lower than those whose physicians decided against the trial and those who proceeded to trial. Patients who did not proceed to the trial at their physicians' request appeared to have significantly worse depression and mental health than those who received the trial. This finding would appear consistent with evidence identifying emotional distress as a predictor of poor SCS outcomes [8] . Lastly, those who did not proceed to the trial at their physicians' request appeared to have significantly lower levels of pain acceptance and committed action than those who did proceed. With the exception of changes in pain intensity, the magnitude of changes in outcome and process variables over treatment did not appear to differentiate patients in terms of whether they proceeded to the implantation trial or the success of their trial. This finding might suggest that the absolute value of scores on posttreatment outcome and process variables has greater predictive utility in this context than the extent of change during treatment. However, given the small proportion of patients not receiving a trial, these findings remain tentative.
This study has limitations. First, there is no control group. This means that the observed changes in process and outcome variables cannot be unambiguously attributed to the ACT-based interdisciplinary treatment. However, previous research has shown that patients with comparable levels of distress and disability to the current sample do not experience significant improvements during an average 4-month waiting phase prior to receiving a similar ACT-based interdisciplinary treatment [32] . This would appear to suggest that the changes observed in our study do not merely reflect patients' natural recovery trajectory or regression to the mean. Another important limitation is the lack of follow-up assessment. From these data, we do not know whether the changes observed are likely to endure or what outcomes will eventually be achieved when the neuromodulation procedures are complete. However, previous studies have suggested that the benefits of ACT-based interdisciplinary treatments for chronic pain appear robust up to 3 years post-treatment [33] and that further gains may occur during follow-up, after the completion of a brief ACT-based treatment [34] . Future research is needed to determine long-term outcomes associated with the ACT-based "preneuromodulation" treatment examined here. Finally, this study was conducted in one treatment center. Therefore, future research is needed to examine the reliability and generalizability of the present findings.
In summary, people awaiting a medical intervention to reduce pain appear able to benefit from a psychologically based interdisciplinary treatment aimed to improve their functioning and quality of life without reducing pain.
Hence, it appears that when faced with chronic pain, people can learn to respond with flexibility and, to a degree, embrace some contradictions. It appears that they can both seek relief from pain, perhaps as a longerterm issue, and learn to face pain, as a moment-tomoment issue, when it is a part of an overall approach to achieving better health and daily activity. There are remaining questions about the long-term outcome of ACT-based treatments in this context and the best ways to combine pain-reducing and function-enhancing treatments to optimize their synergistic effects.
